arrow attorney-female attorney-male btn-close btn-menu checkmark document facebook ArtboardCreated with Sketch. instagram linkedin play twitter youtube
Attorney Referrals
Free Case Review - 24/7 - Nationwide
(888) 485-8844

Quick Search

Search results will appear here
Ferrer Poirot Wansbrogh Feller Daniel Logo
  • About Us
    • Meet Our Attorneys
    • FAQ
  • Cases We Handle
  • Contact Us
  • Attorney Referrals
Ferrer Poirot Wansbrogh Feller Daniel Logo
  • About Us
    • Meet Our Attorneys
    • FAQ
  • Cases We Handle
  • Contact Us
  • Attorney Referrals
Free Case Review - 24/7 - Nationwide

Search Results

Search Results: arthritis

Actemra
In 2010, the U.S. Food and Drug Administration (FDA) approved Actemra (tocilizumab) to treat symptoms of rheumatoid arthritis, a condition that affects more than 1.5 million Americans. Upon its approval, the drug showed fewer initial side effects than other treatments—a factor that encouraged doctors to prescribe the drug to their patients. In fact, gross sales for Actemra totaled $1.7 billion in 2016, and (more...)
Ferrer Poirot Wansbrogh Feller Daniel Logo
  • Blog
  • Disclaimer
  • Privacy Policy
  • Sitemap
Principal Office: 2603 Oak Lawn, Suite 300, Dallas, Texas 75219

Tel: (800) 210-8503

No fee if no recovery. You will never pay court costs and expenses we incur unless we settle your claim. Client is obligated for payment of court costs and expenses, such as medical expenses. Cases may be referred for the purpose of advancing your claim with your best interests as our primary concern. Attorneys Jesse Ferrer and Matt Daniel are responsible for the content of this website.

2023 © All rights reserved Ferrer, Poirot & Wansbrough | Law Firm Marketing by cj Advertising